Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025 and May 2026.
- Largest single sale: $7.1M (210,468 shares) of Immunovant, Inc. on May 28, 2026. Filing
- Last sale before this period: Mar 7, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Immunovant, Inc. (IMVT) | Director | Dec 20, 2019 | May 29, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 28, 2026, Immunovant, Inc.: sold 221,951 shares for $7.4M, no plan disclosed; 196,601 shares acquired by exercising options. 1 filing: 1
- Apr 7, 2026, Immunovant, Inc.: 13,880 shares granted. 1 filing: 1
- Dec 1, 2025, Immunovant, Inc.: sold 22,249 shares for $517K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.